2014 Coverage, Reimbursement & Health Policy Conference Agenda


click here to print Agenda


Wednesday, November 12, 2014

1:00pm - 5:00pm

Registration (program begins at 1:30pm)

1:30pm - 5:00pm

An Introduction to Reimbursement

          1:30pm - 3:00pm     Getting Paid for Your Medical Device:

                                                Understanding, Planning and Securing Reimbursement

  • Judy Rosenbloom, Founder & President, JR Associates
  • Jo Ellen Slurzberg, Vice President, Global Health Policy/Reimbursement, JR Associates

"Will my device get reimbursed?" It is a fundamental question that medical device manufacturers must answer at every stage of product development. Early, investors want assurance of a return on their investment. Ultimately, customers-hospitals and physicians want to know they can access the device for patients, bill and be paid for it, and preserve their bottom line. Patients are worried about out-of-pocket costs and want to know if their insurance will cover and pay.

Importantly, manufacturers need to understand how reimbursement influences access; how payers and providers evaluate clinical evidence supporting the adoption of technology; and how the reimbursement pathway changes because of the site of service where the technology is used. JR Associates will weave the basics of medical device reimbursement (coverage, codes and payment) in the current and evolving healthcare environment, and will focus on creating an implemental strategy that highlights the value proposition for a product so it can be successfully commercialized.

          3:00pm - 3:20pm     Networking Break

          3:20pm - 5:00pm        Idea Exchange

At the end of the session, JR Associates will facilitate an idea exchange with participants to discuss product-specific reimbursement questions and issues to begin to put this information into practice. Participants can introduce their own questions as part of this session.

5:00pm - 6:00pm

Networking Reception

Thursday, November 13, 2014

7:30am - 8:55am

Registration and Continental Breakfast

8:55am - 9:00am

Welcoming Remarks

  • Mark Leahey, President & CEO, MDMA

9:00am - 9:30am

Breaking Down Health Care Costs, Trends & Concerns

It seems every decision being made in health care today is boiling down to "How much does it cost, and who is paying for it?" This presentation will analyze the $2.8 trillion in the U.S. health care system, and provide objective data on the real cost drivers. In addition, it will shed light on the greatest opportunities to improve the system and make it more efficient moving forward.

  • Mark Leahey, President & CEO, MDMA

9:30am - 10:15am

Developing the Right Clinical Evidence to Support Your Technology

The design of your clinical trial is often the "make or break" decision that impacts your ability to obtain adequate reimbursement. Learn the latest factors your team must consider to help ensure you are ready to confront the challenges in developing robust clinical evidence.

  • Louis Jacques, M.D., Senior Vice President & Chief Clinical Officer, ADVI
  • Bryan Olin, Vice President, Clinical, Quality & Regulatory, Cyberonics, Inc.
  • Murray Sheldon, M.D., Associate Director for Technology and Innovations, CDRH
  • Chuck Shih, Health Policy Fellow, National Pharmaceutical Council, George Washington University
  • Mark Leahey, President & CEO, MDMA (Moderator)

10:15am - 10:30am

Networking Break

10:30am - 11:15am

Medicare Coverage for Devices

Hear from CMS's Director of Coverage & Analysis Group on what policies the agency is focusing efforts and resources on as they adjust to the latest reforms.

  • Tamara Syrek Jensen, Director, Coverage and Analysis Group, Center for Clinical Standards and Quality, Centers for Medicare & Medicaid Services

11:15am - 12:00pm

Best Practices to Successfully Gain Coverage with Private Payers

Creating a reimbursement strategy is challenging and complex. You will need to understand the mechanics related to coding, coverage decisions, payers, and more. Coverage and payment policies vary from payer to payer, and industry experts will share the best practices for successfully gaining coverage for your device.

  • Stanley Jackson, Senior Director, Global Government Affairs, Cyberonics, Inc.
  • Paul Martino, Co-Founder & Chief Strategy Officer, VillageMD, former SVP of Clinical Strategy & Innovation for WellPoint
  • Mark Leahey, President & CEO, MDMA (Moderator)

12:00pm - 1:00pm

Networking Luncheon

1:00pm - 1:45pm

Navigating the Current Procedural Terminology (CPT) Process

While the CPT process can be confusing and challenging, a former AMA CPT Director will help you navigate through the coding labyrinth and provide strategy for policy planning and maximizing your product's reimbursement.

  • Michael Beebe, Senior Vice President, ADVI, former Director of CPT at AMA
  • Mark Wagner, President & CEO, Celleration, Inc.

1:45pm - 2:45pm

Value of Technology Roundtable

How do different players quantify value in the healthcare ecosystem? And what are the metrics and value propositions that payors are looking for today? Learn what you and your team need to be ready for in the new reimbursement landscape.

  • Campbell Rogers, M.D., Chief Medical Officer, HeartFlow, Inc.
  • Ann Roy, Senior Manager for Health Economics & Reimbursement, Boston Scientific Corporation
  • Alan Sokolow, Senior Vice President, ADVI and former BCBS CMO
  • Patrick Sorrentino, Healthcare Executive & past CEO tenet Healthcare, Chicago Health System
  • Mark Leahey, President & CEO, MDMA (Moderator)

2:45pm - 3:00pm

Networking Break

3:00pm - 3:45pm

International Reimbursement Issues

International Reimbursement issues continue to change and present problems for medical device manufacturers. Learn about China's freeze on new product codes, Russia's ban on public funding for certain imported devices, and the UK's web based formularies for devices and more.

  • Stephen Hull, Principal & Founder, Hull Associates

3:45pm - 4:30pm

Payment Reforms, New Payment Models, & What it Means to You

From Accountable Care Organizations (ACOs) to bundled payments and more, the payment models for medical technology innovators have never been more complex. Learn what pitfalls - and opportunities - you and your team need to know about as you confront the new environment.

  • Ron Barkley, MS, JD, President, Cancer Center Business Development Group
  • Lauren Buckley, Group Vice President, Health Policy & Reimbursement, Kimbell & Associates
  • Elizabeth Halpern, Partner, Hogan Lovells





Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of canceled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.